Safety of Nintedanib in Real World in China

NCT05676112 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Pulmonary Fibrosis

Interventions

DRUG: nintedanib
DRUG: pirfenidone

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]